Jonathan Thevenet Selected Research

JNK Mitogen-Activated Protein Kinases

11/2009	Coagulation factor Xa activates thrombin in ischemic neural tissue.
7/2004	D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan Thevenet Research Topics

Disease

5	Ischemia 08/2013 - 07/2004
4	Brain Ischemia (Cerebral Ischemia) 08/2013 - 07/2004
3	Insulinoma 01/2019 - 03/2014
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2009 - 07/2004
1	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 11/2020
1	Disease Progression 11/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2020
1	Ischemic Stroke 11/2009
1	Infarction (Infarctions) 07/2004

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 11/2009
3	Thrombin FDA Link 08/2013 - 05/2007
2	Neuroprotective AgentsIBA 08/2013 - 07/2004
2	Oxygen (Dioxygen)IBA 08/2013 - 11/2009
2	JNK Mitogen-Activated Protein KinasesIBA 11/2009 - 07/2004
1	succinyl-coenzyme A (succinyl-CoA)IBA 11/2020
1	Ligases (Synthetase)IBA 11/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	Lysine (L-Lysine)FDA Link 01/2019
1	GalactosidasesIBA 08/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2013
1	Peptide Hydrolases (Proteases)FDA Link 08/2013
1	EnzymesIBA 11/2009
1	Prothrombin (Factor II)IBA 11/2009
1	Fondaparinux (Arixtra)FDA Link 11/2009
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2009
1	Serine Proteases (Serine Protease)IBA 05/2007
1	D-JNKI-1IBA 07/2004

Therapy/Procedure

1	Sutures (Suture) 07/2004